搜尋結果
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, [1] among others, is a subunit COVID-19 vaccine developed by Novavax and the Coalition for Epidemic Preparedness Innovations. [31] . It contains a recombinant spike protein from the SARS-CoV-2 Omicron variant lineage JN.1. [30] Medical uses.
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases.
Matrix-M is a vaccine adjuvant, a substance that is added to various vaccines to stimulate the immune response. [1][2][3] It was patented in 2020 by Novavax [4] and is composed of nanoparticles from saponins extracted from Quillaja saponaria (soapbark) trees, cholesterol, and phospholipids. [5][6][7] It is an immune stimulating complex (ISCOM), ...
On the same day, Novavax stated that it was developing an updated vaccine requiring two doses for the Omicron variant, which the company expected to be ready for testing and manufacturing within a few weeks.
"NOVAVAX, a pharmaceutical company in Rockville, Md., announced this week that in preliminary results of two phase 1 clinical trials, its H5N1 avian influenza vaccine candidate was found to be safe and effective.
File:Novavax-logo.svg. Size of this PNG preview of this SVG file: 512 × 249 pixels. Other resolutions: 320 × 156 pixels | 640 × 311 pixels | 1,024 × 498 pixels | 1,280 × 623 pixels | 2,560 × 1,245 pixels. Original file (SVG file, nominally 512 × 249 pixels, file size: 554 KB) This is a file from the Wikimedia Commons. Information ...
Covaxin (development name, BBV152) is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research - National Institute of Virology. [1]On 3 November 2021, the World Health Organization (WHO) validated the vaccine for emergency use, as the first Indian-developed covid vaccine to be approved.
